Exploitant pharmaceutical site - Page 2

Medicine prices: is France still an attractive market?

In the European Union, decisions on pricing and reimbursement of medicinal products are made at a national level following negotiations between governments and Marketing Authorisation Holders (MAH). In France, after obtaining

International women's day

Every year on 8th March, International Women's Day is celebrated in many countries. This day, is dedicated to celebrating victories and achievements in women's rights and to reaffirming the importance of the struggle for women's r

AxeRegel celebrates its 5th anniversary

Today we are celebrating AxeRegel’s 5th anniversary!Celebrate with us!AxeRegel is a regulatory affairs consultancy company focused on providing services in:Regulatory affairsQualityPharmacovigilanceMedical informationfor the pharm

Applying for orphan drug designation (ODD)

An orphan medicinal product is a medicine for the diagnosis, prevention or treatment of a life-threatening or chronically debilitating condition that is rare (affecting not more than five in 10,000 people in the European Union) or